Growth Metrics

Globus Medical (GMED) Cash from Investing Activities Growth (1y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -4,224.26%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 95.53%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 3.20%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -18.20%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -208.79%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -187.82%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -397.90%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -514.25%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -211.17%
10 Globus Medical 10.79 Bn 10.16 Bn 525.79 Mn -239.04%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -239.04%
Dec 31, 2025 -7.04%
Sep 30, 2025 -406.73%
Jun 30, 2025 -2,782.14%
Mar 31, 2025 382.04%
Dec 31, 2024 -132.48%
Sep 30, 2024 81.49%
Jun 30, 2024 -119.87%
Mar 31, 2024 -523.80%
Dec 31, 2023 630.08%
Sep 30, 2023 -28.13%
Jun 30, 2023 92.52%
Mar 31, 2023 179.11%
Dec 31, 2022 75.19%
Sep 30, 2022 -816.63%
Jun 30, 2022 19,069.23%
Mar 31, 2022 88.89%
Dec 31, 2021 -104.71%
Sep 30, 2021 -189.87%
Jun 30, 2021 95.67%
Mar 31, 2021 -4,726.93%
Dec 31, 2020 -230.49%
Sep 30, 2020 156.05%
Jun 30, 2020 91.02%
Mar 31, 2020 95.19%
Sep 30, 2019 83.23%
Jun 30, 2019 33.72%
Mar 31, 2019 4.05%
Sep 30, 2018 -131.83%
Jun 30, 2018 -15.89%
Mar 31, 2018 -413.49%
Dec 31, 2017 75.04%
Sep 30, 2017 23.95%
Jun 30, 2017 -342.46%
Mar 31, 2017 69.75%
Dec 31, 2016 -83.59%
Sep 30, 2016 -102.34%
Jun 30, 2016 77.72%
Mar 31, 2016 17.49%
Dec 31, 2015 58.54%
Sep 30, 2015 -505.19%
Jun 30, 2015 -399.94%
Mar 31, 2015 -108.70%
Dec 31, 2014 -99.16%
Sep 30, 2014 86.58%
Jun 30, 2014 130.43%
Mar 31, 2014 79.01%
Dec 31, 2013 -499.92%
Sep 30, 2013 -150.81%
Jun 30, 2013 -860.24%
Mar 31, 2013 -1,483.38%
Dec 31, 2012 -12.65%
Sep 30, 2012 -207.65%